02325.HK
Yunkang Group Limited
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 0.47
−4.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 40.42x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.01x
- PEG TTM
- —
- Price / book
- 0.20x
- Price / sales
- 0.43x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- -HKD 831.8M
- EV / sales
- -1.32x
- EV / EBITDA
- -6.25x
- EV / EBIT
- -8.27x
- Market cap
- HKD 272.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026